EGFR and head and neck squamous cell carcinoma: Thus, it is possible that the endogenous levels of EGFR and/or EGFR ligands directly impact on the efficacy of EGFR blockade, especially in HPV‐negative (mostly TP53mut) HNSCC (Wheeler et al,2010; Huang et al,2021).